Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK1 | P04629 | 3/20 | 0.33 |
| ▸ | DHODH | Q02127 | 3/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.32 |
| ▸ | SLC2A3 | P11169 | 2/20 | 0.32 |
| ▸ | SLC2A4 | P14672 | 2/20 | 0.32 |
| ▸ | SLC2A2 | P11168 | 1/20 | 0.32 |
| ▸ | MALT1 | Q9UDY8 | 3/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.30 |
| ▸ | STIM1 | Q13586 | 1/20 | 0.30 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL687025 | 0.94 | DHODH (0.32) | NTRK1DHODHMALT1 | |
| SCHEMBL13085129 | 0.94 | DHODH (0.33) | NTRK1DHODHSLC2A1SLC2A3SLC2A4 | |
| SCHEMBL13085032 | 0.94 | NTRK1 (0.34) | NTRK1DHODHMALT1LMNAPOLB | |
| SCHEMBL11928398 | 0.94 | NTRK1 (0.34) | NTRK1DHODHSLC2A1SLC2A3SLC2A4 | |
| SCHEMBL13085016 | 0.93 | DHODH (0.35) | NTRK1DHODHSLC2A1SLC2A3SLC2A4 | |
| SCHEMBL11928601 | 0.93 | DHODH (0.34) | NTRK1DHODHSLC2A1SLC2A3SLC2A4 | |
| SCHEMBL684739 | 0.93 | DHODH (0.32) | NTRK1DHODHSLC2A1SLC2A3SLC2A4 | |
| SCHEMBL13085417 | 0.93 | NTRK1 (0.32) | NTRK1PDE10ANR3C1 | |
| SCHEMBL684744 | 0.93 | DHODH (0.32) | NTRK1DHODHSLC2A1SLC2A3SLC2A4 | |
| SCHEMBL685550 | 0.93 | SLC2A1 (0.36) | NTRK1DHODHSLC2A1SLC2A3SLC2A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9968086-B2 | Active ingredient combinations having insecticidal and acaricidal properties | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2018-05-15 | — | — | US | disclosed |
| US-9968086-B2 | Active ingredient combinations having insecticidal and acaricidal properties | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2018-05-15 | — | — | US | disclosed |
| US-9854802-B2 | Use of an anthranilic diamide derivatives with heteroaromatic and heterocyclic substituents in combination with a biological control agent | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2018-01-02 | — | — | US | disclosed |
| US-20170265470-A1 | Anthranilamides in combination with fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2017-09-21 | — | — | US | disclosed |
| US-20170265470-A1 | Anthranilamides in combination with fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2017-09-21 | — | — | US | disclosed |
| US-9700049-B2 | Anthranilamides in combination with fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2017-07-11 | — | — | US | disclosed |
| US-9700049-B2 | Anthranilamides in combination with fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2017-07-11 | — | — | US | disclosed |
| US-20170156328-A1 | USE OF AN ANTHRANILIC DIAMIDE DERIVATIVES WITH HETEROAROMATIC AND HETEROCYCLIC SUBSTITUENTS IN COMBINATION WITH A BIOLOGICALCONTROL AGENT | BAYER INTELLECTUAL PROPERTY GMBH | 2017-06-08 | — | — | US | disclosed |
| US-20170156328-A1 | USE OF AN ANTHRANILIC DIAMIDE DERIVATIVES WITH HETEROAROMATIC AND HETEROCYCLIC SUBSTITUENTS IN COMBINATION WITH A BIOLOGICALCONTROL AGENT | BAYER INTELLECTUAL PROPERTY GMBH | 2017-06-08 | — | — | US | disclosed |
| US-9572342-B2 | Use of an anthranilic diamide derivatives with heteroaromatic and heterocyclic substituents in combination with a biologicalcontrol agent | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2017-02-21 | — | — | US | disclosed |
| US-20120022112-A1 | USE OF ANTHRANILAMIDE DERIVATIVES FOR CONTROLLING INSECTS AND SPIDER MITES BY DRENCHING, SOIL MIXING, FURROW TREATMENT, DRIP APPLICATION, SOIL, STEM OR FLOWER INJECTION, IN HYDROPONIC SYSTEMS, BY PLANTING HOLE TREATMENT OR DIP APPLICATION, FLOATING OR SEEDBOX APPLICATION OR BY TREATING SEED, AND ALSO FOR ENHANCING THE STRESS TOLERANCE OF PLANTS TO ABIOTIC STRESS | BAYER CROPSCIENCE AG (DE) | 2012-01-26 | — | — | US | disclosed |
| WO-2012010525-A2 | USE OF ANTHRANILIC ACID AMIDE DERIVATIVES FOR CONTROLLING INSECTS AND SPIDER MITES BY WATERING, MIXING WITH SOIL, DRENCH TREATMENT, DROPLET APPLICATION, INJECTION INTO THE SOIL, STEMS OR BLOSSOMS, IN HYDROPONIC SYSTEMS, BY TREATING THE PLANTING HOLE OR IMMERSION APPLICATION, FLOATING OR SEED BOX APPLICATION OR BY THE TREATMENT OF SEEDS, AND FOR INCREASING THE STRESS TOLERANCE IN PLANTS TO ABIOTIC STRESS | BAYER CROPSCIENCE AG (DE) | 2012-01-26 | — | — | WO | disclosed |
| US-20120010073-A1 | Anthranilamides in combination with fungicides | BAYER CROPSCIENCE AG (DE) | 2012-01-12 | — | — | US | disclosed |
| US-20120010073-A1 | Anthranilamides in combination with fungicides | BAYER CROPSCIENCE AG (DE) | 2012-01-12 | — | — | US | disclosed |
| WO-2011157778-A1 | ACTIVE SUBSTANCE COMBINATIONS WITH INSECTICIDE AND ACARICIDE PROPERTIES | BAYER CROPSCIENCE AG (DE) | 2011-12-22 | — | — | WO | disclosed |
| US-20110311503-A1 | Active ingredient combinations having insecticidal and acaricidal properties | BAYER CROPSCIENCE AG (DE) | 2011-12-22 | — | — | US | disclosed |
| US-20110311503-A1 | Active ingredient combinations having insecticidal and acaricidal properties | BAYER CROPSCIENCE AG (DE) | 2011-12-22 | — | — | US | disclosed |
| US-20100256195-A1 | Tetrazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2010-10-07 | — | — | US | disclosed |
| US-20100256195-A1 | Tetrazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2010-10-07 | — | — | US | disclosed |
| WO-2010069502-A2 | TETRAZOLE SUBSTITUTED ANTHRANILIC ACID AMIDES AS PESTICIDES | BAYER CROPSCIENCE AG (DE) | 2010-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256195-A1 | Tetrazole-substituted anthranilamides as pesticides | ANTXR2, PNISR, H1-5 | NTRK1 2506/4885DHODH 2604/4885SLC2A1 2324/4885 |
| US-20120010073-A1 | Anthranilamides in combination with fungicides | AADAC, ANTXR2, CYP51A1 | NTRK1 4774/4885DHODH 815/4885SLC2A1 4485/4885 |
| US-20120022112-A1 | USE OF ANTHRANILAMIDE DERIVATIVES FOR CONTROLLING INSECTS AND SPIDER MITES BY DRENCHING, SOIL MIXING, FURROW TREATMENT, DRIP APPLICATION, SOIL, STEM OR FLOWER INJECTION, IN HYDROPONIC SYSTEMS, BY PLANTING HOLE TREATMENT OR DIP APPLICATION, FLOATING OR SEEDBOX APPLICATION OR BY TREATING SEED, AND ALSO FOR ENHANCING THE STRESS TOLERANCE OF PLANTS TO ABIOTIC STRESS | CDY1; CDY1B, DHX9, DHX29 | NTRK1 3877/4885DHODH 265/4885SLC2A1 2970/4885 |
| US-20170265470-A1 | Anthranilamides in combination with fungicides | AADAC, ANTXR2, CYP51A1 | NTRK1 4774/4885DHODH 815/4885SLC2A1 4485/4885 |
| US-20170156328-A1 | USE OF AN ANTHRANILIC DIAMIDE DERIVATIVES WITH HETEROAROMATIC AND HETEROCYCLIC SUBSTITUENTS IN COMBINATION WITH A BIOLOGICALCONTROL AGENT | CYC1, TPD52L2, DBF4 | NTRK1 4471/4885DHODH 165/4885SLC2A1 4830/4885 |
| US-20110311503-A1 | Active ingredient combinations having insecticidal and acaricidal properties | ACHE, ACAT1, ACAT2 | NTRK1 4722/4885DHODH 1758/4885SLC2A1 4309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.